Body Mass Index, Natriuretic Peptides, and Risk of Adverse Outcomes in Patients With Heart Failure and Preserved Ejection Fraction: Analysis From the TOPCAT Trial

Journal of the American Heart Association - United Kingdom
doi 10.1161/jaha.118.009664
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Impact of Sex on Ventricular‐Vascular Stiffness and Long‐Term Outcomes in Heart Failure With Preserved Ejection Fraction: TOPCAT Trial Substudy

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2019English

Perturbations in Serum Chloride Homeostasis in Heart Failure With Preserved Ejection Fraction: Insights From TOPCAT

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Marked Elevation of B-Type Natriuretic Peptide in Patients With Heart Failure and Preserved Ejection Fraction

Journal of Biomedical Research
BiochemistryMedicineGeneticsMolecular Biology
2014English

Calcium Channel Blockers and Outcomes in Older Patients With Heart Failure and Preserved Ejection Fraction

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2014English

Insulin Treatment and Clinical Outcomes in Patients With Diabetes and Heart Failure With Preserved Ejection Fraction

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2019English

Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2018English

Prognosis in Heart Failure With Preserved Ejection Fraction

sudan heart journal
2017English

Heart Failure With Preserved Ejection Fraction: Readmission Outcomes Analysis in a Single Center Registry

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2016English

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy